No. It was only on June 16, 2020 that Janssen Pharmaceuticals finally updated Elmiron's warning label to include retinal problems. The Food and Drug Administration (FDA) first approved Elmiron in 1996, so the drug has been on the market for 24 years without any warning about the severe eye maladies it can cause.